VIDEX EC - 54868-5595-0 - (didanosine)

Alphabetical Index


Drug Information of VIDEX EC

Product NDC: 54868-5595
Proprietary Name: VIDEX EC
Non Proprietary Name: didanosine
Active Ingredient(s): 250    mg/1 & nbsp;   didanosine
Administration Route(s): ORAL
Dosage Form(s): CAPSULE, DELAYED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of VIDEX EC

Product NDC: 54868-5595
Labeler Name: Physicians Total Care, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021183
Marketing Category: NDA
Start Marketing Date: 20060519

Package Information of VIDEX EC

Package NDC: 54868-5595-0
Package Description: 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (54868-5595-0)

NDC Information of VIDEX EC

NDC Code 54868-5595-0
Proprietary Name VIDEX EC
Package Description 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (54868-5595-0)
Product NDC 54868-5595
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name didanosine
Dosage Form Name CAPSULE, DELAYED RELEASE
Route Name ORAL
Start Marketing Date 20060519
Marketing Category Name NDA
Labeler Name Physicians Total Care, Inc.
Substance Name DIDANOSINE
Strength Number 250
Strength Unit mg/1
Pharmaceutical Classes Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]

Complete Information of VIDEX EC


General Information